Edition:
United States

AMAG Pharma announces proposed offering of $250 mln of convertible senior notes due 2022


Wednesday, 3 May 2017 04:17pm EDT 

May 3 (Reuters) - AMAG Pharmaceuticals Inc :AMAG Pharmaceuticals Inc announces proposed offering of $250 million of convertible senior notes due 2022.AMAG Pharmaceuticals Inc says notes will pay interest semiannually and will mature on june 1, 2022.AMAG Pharmaceuticals Inc -intends to use net proceeds from offering of notes together with cash on hand to repay approximately $320.8 million of borrowings.AMAG Pharmaceuticals Inc says may enter into privately negotiated transactions with certain holders of its existing 2.50% convertible senior notes due 2019.